MAPT and Alzheimer disease: MARK2 had previously been linked to AD; for example, MARK2-mediated phosphorylation weakens the interaction of tau with microtubules and promotes tau’s cytosolic accumulation39,61 and certain MARK2 sites, such as Ser262, Ser324, and Ser396, are elevated in AD62.